Syndicate Feeds
HIVandHepatitis.com New HCV HepC NS5A Inhibitor ACH-3102 Enters Clinical Trials, Gets FDA Fast-Track Status: http://t.co/0vy6s5btAbout an hour ago
HIVandHepatitis.com HIV Infection Associated with Increased Risk of Sudden Cardiac Death: http://t.co/DRnGTvkgAbout an hour ago
HIVandHepatitis.com Ribavirin Helps Early HepC HCV Treatment in People with HIV: http://t.co/gZVdVEB6Monday, 14 May 2012 14:41
HIVandHepatitis.com Researchers Identify Compounds that May Block HPV 's Ability to Cause Cancer: http://t.co/QeP2dRO3Monday, 14 May 2012 14:40
- Error
FDA Committee Recommends Approval of First Home HIV Test
On May 11, 2012, the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) recommended approval of Gilead Sciences' 4-in-1 once-daily single-tablet antiretroviral regimen known as the Quad. A final decision in expected by late summer.
HIV/AIDS
HIV Gene Therapy Shows Long-term Safety and Activity after 11 Years
Genetically modified T-cells engineered to attack HIV were still present and sho...
FDA Committee Will Consider Approval of Truvada for HIV PrEP this Thursday
On May 10, 2012, the Antiviral Drugs Advisory Committee of the U.S. Food and Dru...
Oral HIV Tests May Be Less Accurate than Blood Tests
Oral HIV antibody testing is quick and convenient, but this method is not quite ...
ACT UP at 25
The AIDS Coalition to Unleash Power, better known as ACT UP, held its first majo...
Hepatitis B
EASL: Telbivudine Effective for Hepatitis B Patients Selected with Roadmap
Telbivudine (Tyzeka) is an effective treatment for chronic hepatitis B with mini...
CDC Advisory Committee Recommends Hepatitis B Vaccine for People with Diabetes
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immun...
Interpreting Hepatitis B Tests
The following table from the U.S. Centers for Disease Control and Prevention (CD...
EASL: Brivanib Did Not Improve Overall Liver Cancer Survival, but Did Show Anti-tumor Activity
The experimental cancer drug brivanib did not lengthen overall survival for pati...
Hepatitis C
EASL: MicroRNA Miravirsen Looks Safe and Effective for Genotype 1 Hepatitis C
Miravirsen, the first microRNA therapy for hepatitis C, was well-tolerated and d...
Scientists Find Antibodies that Neutralize Multiple Strains of Hepatitis C Virus
As described in a report published in the April 4, 2012, online edition of Proceed...
AASLD: HCV Screening of 1945-1965 Birth Cohort Appears Cost-Effective
Screening all people in the U.S. in the 46 to 66 year age group for hepatitis C ...
Anemia during Hepatitis C Treatment Predicts Sustained Response to Pegylated Interferon/ribavirin
Hepatitis C patients who develop anemia during treatment with pegylated int...
Coinfection
CROI: Detectable HIV Raises Risk of Incomplete Hepatitis B Suppression
HIV/HBV coinfected people with detectable HIV viral load and higher baseline HBV...
Ribavirin Helps Early Hepatitis C Treatment in People with HIV
Adding ribavirin to pegylated interferon increases the likelihood of a cure for ...
Other Infections
March 24 is World TB Day
Tuberculosis (TB) is the leading cause of death for people with HIV worldwide --...
Researchers Report Setbacks on Herpes Simplex Vaccine and Treatment
An experimental herpes simplex virus (HSV) vaccine partially protected women aga...
Researchers Identify Compounds that May Block HPV's Ability to Cause Cancer
Researchers have identified a set of compounds known as thiadiazolidinediones th...
Hepatitis E Uncommon among HIV+ People, but May Cause Unexplained Liver Enzyme Elevations
Coinfection with hepatitis E virus (HEV) is not commonly seen in people with HIV...
CONTINUING MEDICAL EDUCATION
Subscribe To Our Newsletter
Sign up for our free twice-weekly e-newsletter
CONFERENCE COVERAGE
47th International Liver Congress (EASL 2012)
April 18-22, 2012, Barcelona
|
19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) |
|
|
The Liver Meeting (AASLD 2011) |
|
|
49th Annual Meeting of the Infectious Disease Society of America (IDSA 2011) |
|
|
13th European AIDS Conference (EACS 2011) |
|
|
51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2011) |
|
|
6th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2011) |
|
|
|
46th Annual Meeting of the European Association for the Study of the Liver (EASL 2011) March 30-Apr. 3, 2011, Berlin |
|
|
18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) |
